About Assertio (ASRT)
Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Susp... Read more
- USD1.54
- USD1.58
- USD1.48
- USD5.78
- 22.50%
- 142M
- 1.57M
- 1.25M
- 156M
- 0.73
- -73.40%
Stock News
5 hours ago
1 Wall Street Analyst Thinks Tesla Stock Is Going to $258. Is It a Buy After a Post-Earnings Pullback?
Yahoo
7 hours ago
Warren Buffett Is in a Selling Mood. What’s Next?
Yahoo
7 hours ago
Weekly Market Outlook: Central Banks And U.S. Earnings. Will The BoJ Hike Rates?
SeekingAlpha
yesterday
Ackman’s Pershing Square USA says IPO is still happening, despite NYSE delay notice
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
